The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems
Article first published online: 12 FEB 2009
© 2009 Blackwell Publishing Ltd
Influenza and Other Respiratory Viruses
Volume 3, Issue 2, pages 51–58, March 2009
How to Cite
Brammer, L., Budd, A. and Cox, N. (2009), Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems. Influenza and Other Respiratory Viruses, 3: 51–58. doi: 10.1111/j.1750-2659.2009.00077.x
- Issue published online: 2 MAR 2009
- Article first published online: 12 FEB 2009
- Accepted 17 January 2009. Published Online 12 February 2009.
- morbidity surveillance;
- mortality surveillance;
- novel influenza A viruses;
- virologic surveillance
Abstract Surveillance for influenza is essential for the selection of influenza vaccine components and detection of human infections with novel influenza A viruses that may signal the start of a pandemic. Virologic surveillance provides the foundation from which this information can be obtained. However, morbidity and mortality data are needed to better understand the burden of disease, which, in turn, can provide useful information for policy makers relevant to the allocation of resources for prevention and control efforts. Data on the impact of influenza can be used to identify groups at increased risk for severe influenza-related complications, develop prevention and control policies, and monitor the effect of these policies. Influenza surveillance systems frequently monitor outpatient illness, hospitalizations, and deaths, but selection of influenza surveillance components should be based on the surveillance goals and objectives of the jurisdiction.